Senate Bill 876 (2025) — Chimeric antigen receptor T-cell therapy

SB 876

Florida Bills

Florida Senate - 2025 SB By Senator Berman 26-01316-25 2025876__ CODING: Words stricken are deletions; words underlined are additions. A bill to be entitled

An act relating to chimeric antigen receptor T-cell therapy; creating ss. 627.64198, 627.6614, and 3 641.31078, F.S.; prohibiting health insurers and health maintenance organizations issuing, delivering, 5 or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy; providing an effective date. 9

Be It Enacted by the Legislature of the State of Florida: 11

Section

Section 627.64198, Florida Statutes, is created to read: 14 627.64198 CAR-T therapy providers.—A health insurer issuing, delivering, or renewing a health insurance policy in this state on or after January 1, 2026, which provides coverage for chimeric antigen receptor T-cell (CAR-

T) therapy may not refuse to contract with or deny coverage for the administration of CAR-T therapy by any provider that qualifies as a certified health care facility under the Food and Drug Administration procedure for the CAR-T product license and that is included in the policy’s provider network for any other service. 23

Section

Section 627.6614, Florida Statutes, is created to read: 25 627.6614 CAR-T therapy providers.—A health insurer issuing, 26 delivering, or renewing a group health insurance policy in this state on or after January 1, 2026, which provides coverage for chimeric antigen receptor T-cell (CAR-

T) therapy may not refuse Florida Senate - 2025 SB 876 26-01316-25 2025876__ CODING: Words stricken are deletions; words underlined are additions. to contract with or deny coverage for the administration of CAR-30 T therapy by any provider that qualifies as a certified health care facility under the Food and Drug Administration procedure for the CAR-T product license and that is included in the policy’s provider network for any other service. 34

Section

Section 641.31078, Florida Statutes, is created to read: 36 641.31078 CAR-T therapy providers.—A health maintenance organization issuing, delivering, or renewing a health maintenance contract in this state on or after January 1, 2026, 39 which provides coverage for chimeric antigen receptor T-cell 40 (CAR-

T) therapy may not refuse to contract with or deny coverage for the administration of CAR-T therapy by any provider that qualifies as a certified health care facility under the Food and Drug Administration procedure for the CAR-T product license and that is included in the policy’s provider network for any other service. 46

Section 4. This act shall take effect January 1, 2026. 47

Document details

CollectionFlorida Bills
CitationSB 876
Typebill
Languageen
Formatpdf
SourceFL_SENATE
Identifier97396e99933df4b7c5b1bb34efa4771c7a296dc0

Source file is stored in the law ingest library (pdf).

Senate Bill 876 (2025) — Chimeric antigen receptor T-cell therapy

SB 876

Florida Bills

Loading PDF viewer…